top of page


New York State Attorney General Investigating Mylan Pharmaceuticals for Unfair Competition
By Jeffrey M. Haber What anticompetitive business actions are considered unfair? Amidst the recent commotion surrounding the wildly elevated prices of certain products sold by Mylan Pharmaceuticals ("Mylan"), New York State Attorney General Eric Schneiderman is investigating whether the drug company has unfairly limited competition. Although Mylan has been accused of profiteering before, this time the product involved is EpiPen®, the emergency injector used for extreme emerge

Jeffrey Haber
Sep 22, 20162 min read
bottom of page
